Important new aspects are revealed about the control of cell division
Credit: University of Seville Experts from the University of Seville and the Andalusian Centre for Molecular Biology and Regenerative Medicine (Cabimer) have published a new...
NEWS INDEX
Dana-Farber/Brigham and Women’s physician wins prestigious recognition from ASH
ATLANTA - Benjamin Ebert, MD, PhD, chair of Medical Oncology at Dana-Farber Cancer Institute in Boston has been named the recipient of the 2017 William...
MRI scans predict patients’ ability to fight the spread of cancer
A simple, non-invasive procedure that can indicate how long patients with cancer that has spread to the brain might survive and whether they are likely...
Medical marijuana for children with cancer? What providers think
A study published in Pediatrics examined interdisciplinary provider perspectives on legal medical marijuana use in children with cancer. It found that 92 percent of providers...
Insights on how SHARPIN promotes cancer progression
Credit: Ronai Lab, Sanford Burnham Prebys Medical Discovery Institute (SBP) La Jolla, Calif., December 11, 2017 - Researchers at Sanford Burnham Prebys Medical Discovery (SBP)...
Researchers invent novel RNA nanotech to decorate exosomes for effective cancer therapy
Columbus, Ohio - A new study shows that attaching antibody-like RNA nanoparticles to microvesicles can deliver effective RNA therapeutics such as small interfering RNA (siRNA)...
Drug suppresses spread of breast cancer caused by stem-like cells
Credit: UC San Diego Health Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway...
Transfusion dependence a barrier to quality end-of-life care for some with leukemia
(Atlanta, Dec. 11, 2017) -- For patients with advanced leukemia, access to high-quality end-of-life care appears to be reduced in those dependent on blood transfusions,...
CAR T-cell therapies drive outcomes in lymphoma, myeloma
Credit: American Society of Hematology (Atlanta, Dec. 10, 2017) -- For people with certain types of aggressive, refractory blood cancers, treatment options are woefully limited....
Survivorship care plan improves cancer care-related distress levels for HCT recipients
MINNEAPOLIS, December 11, 2017 - Patients treated with hematopoietic cell transplantation (HCT), also known as blood and marrow transplant, have a higher risk for long-term...
People aged 75 years and older are underrepresented in blood cancer clinical trials
(Atlanta, Monday, Dec. 11, 2017) -- In the first comprehensive analysis of clinical trial enrollment among older adults with blood cancers, researchers from the U.S....
A new weapon against bone metastasis?
Credit: Courtesy of Kang Lab/Princeton University In the ongoing battle between cancer and modern medicine, some therapeutic agents, while effective, can bring undesirable or even...
Immunotherapy strategy could be beneficial for relapsed acute myeloid leukemia
ATLANTA - University of North Carolina Lineberger Comprehensive Cancer Center researchers report that pairing an immunotherapy drug with chemotherapy proved beneficial for some patients with...
Blueprints for anti-cancer drugs discovered in bacterial genomes
JUPITER, Fla. - Dec. 11, 2017 - Scientists on the Florida campus of The Scripps Research Institute (TSRI) who had previously discovered the prostate cancer-killing...
PharmaMar presents positive results of the pivotal Phase III trial with plitidepsin in MM
With regards to the primary endpoint, in patients who received the combination of plitidepsin with dexamethasone, a 3.8 month progression free survival (PFS) was observed...
